Crossmark

Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure

Crossref DOI link: https://doi.org/10.1007/s10875-018-0480-4

Published Online: 2018-02-06

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Michniacki, Thomas F.

Hannibal, Mark

Ross, Charles W.

Frame, David G.

DuVall, Adam S.

Khoriaty, Rami

Vander Lugt, Mark T.

Walkovich, Kelly J.
License Information

Text and Data Mining valid from 2018-02-01

Version of Record valid from 2018-02-01
More Information

Article History

Received: 20 November 2017

Accepted: 25 January 2018

First Online: 6 February 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflicts of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Document is current

Any future updates will be listed below